Table 2 Treatments according to time quartiles
| Â | All patients | CHT | NCHT | ||||
|---|---|---|---|---|---|---|---|
| Â | Time of assessment (months) | n | percentage | n | percentage | n | percentage |
surgery | 3 | 56 | 60.9% | 19 | 35.2% | 37 | 97.4% |
6 | 15 | 16.3% | 15 | 27.8% | 0 | 0.0% | |
9 | 21 | 22.8% | 20 | 37.0% | 1 | 2.6% | |
12 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | |
radiotherapy | 3 | 24 | 26.1% | 0 | 0.0% | 24 | 63.2% |
6 | 17 | 18.5% | 2 | 3.7% | 15 | 39.5% | |
9 | 44 | 47.8% | 42 | 77.8% | 2 | 5.3% | |
12 | 15 | 16.3% | 15 | 27.8% | 0 | 0.0% | |
chemotherapy | 3 | 54 | 58.7% | 54 | 100.0% | 0 | 0.0% |
6 | 53 | 57.6% | 53 | 98.1% | 0 | 0.0% | |
9 | 19 | 20.7% | 19 | 35.2% | 0 | 0.0% | |
12 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | |
endocrine therapy1 | 3 | 41 | 44.6% | 8 | 14.8% | 33 | 86.8% |
6 | 49 | 53.3% | 15 | 27.8% | 34 | 89.5% | |
9 | 67 | 72.8% | 33 | 61.1% | 34 | 89.5% | |
12 | 71 | 77.2% | 37 | 68.5% | 34 | 89.5% | |
antibody therapy 2 | 3 | 17 | 18.5% | 17 | 30.4% | 0 | 0.0% |
6 | 25 | 27.2% | 25 | 44.6% | 0 | 0.0% | |
9 | 25 | 27.2% | 25 | 44.6% | 0 | 0.0% | |
12 | 25 | 27.2% | 25 | 44.6% | 0 | 0.0% | |
| Â | total | 92 | 100.0% | 54 | 100.0% | 38 | 100.0% |